Abby Scholer

on the atlas — 21

• Guiding pluripotent stem cell therapies past the immune system | Stem Cells Translational Medicine | Oxford Academic1 savers
• AI Prognosis: What David Baker's AI biotech Xaira has been up to1 savers
• Xipu Observation: When AI becomes the "operating system," the gap between drug development and clinical practice is being bridged.1 savers
• Insulin gene-modified 3D stem cells for enhanced islet regeneration and systemic reversal of type 1 diabetes | Stem Cells Translational Medicine | Oxford Academic1 savers
• The transformative impact of stem cell core facilities in biomedical research: Stem Cell Reports1 savers
• Allogeneic islet products for type 1 diabetes: Navigating nonclinical and manufacturing regulatory expectations: Stem Cell Reports1 savers
• Chinese Scientists Transplant Stem Cell-derived Islets to Treat Type 1 Diabetes----Chinese Academy of Sciences1 savers
• America Must Address Early Clinical Development | FDA1 savers
• Pancreatic cancer success story stems from 'undruggable' KRAS target | STAT1 savers
• Beyond the model: Building AI systems that science can trust1 savers
• Rumsfeld Matrix1 savers
• Kalshi introduces prediction markets for clinical trials, FDA approvals1 savers
• Encapsulated islets for diabetes therapy: History, current progress, and critical issues requiring solution - ScienceDirect1 savers
• The latest orphan drug exemptions may not be warranted, analysis finds | STAT1 savers
• Off-the-shelf stem cell therapy for type 1 diabetes yields more positive results1 savers
• Papers provide new clues to spotting type 1 diabetes before onset | STAT1 savers
• How the FDA can catch up with medical software innovation | STAT1 savers
• Medicare's ACCESS chronic care pilot signs up 150 companies | STAT1 savers
• The assisted suicide stories that don’t get told | STAT1 savers
• what are APPs in healthcare? - Google Search1 savers
• _Kim_Engineering immune-evasive islet replacement- cell-intrinsic and peri-graft strategies.pdf - Google Drive1 savers